5-Bromo-2-Chloropyrimidine CAS 32779-36-5 Purity ≥99.5% (HPLC) Macitentan Intermediate Factory

Kufotokozera Kwachidule:

Dzina la Mankhwala: 5-Bromo-2-Chloropyrimidine

CAS: 32779-36-5

Kuyera: ≥99.5% (HPLC)

Maonekedwe: Ufa Woyera mpaka Woyera

Pakati pa Macitentan (CAS: 441798-33-0) pochiza Pulmonary Arterial Hypertension (PAH)

Ubwino Wapamwamba, Kupanga Zamalonda

E-Mail: alvin@ruifuchem.com


Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Manufacturer Commercial Supply Macitentan Related Intermediates
5-(4-Bromophenyl) -4,6-Dichloropyrimidine CAS 146533-41-7
5-Bromo-2-Chloropyrimidine CAS 32779-36-5

Chemical Properties:

Dzina la Chemical 5-Bromo-2-Chloropyrimidine
Mawu ofanana ndi mawu 2-Chloro-5-Bromopyrimidine;Macitentan Wapakatikati 5
Nambala ya CAS 32779-36-5
Nambala ya CAT RF-PI854
Stock Status Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula C4H2BrClN2
Kulemera kwa Maselo 193.43
Melting Point 73.0 ~ 79.0 ℃ (lit.)
Boiling Point 95 ℃/15 mmHg
Kusungunuka Zosungunuka mu Methanol;Zosasungunuka m'madzi
Mtundu Ruifu Chemical

Zofotokozera:

Kanthu Zofotokozera
Maonekedwe Ufa Woyera mpaka Woyera
Chizindikiritso IR/HPLC
Kuyera / Kusanthula Njira ≥99.5% (HPLC)
Chinyezi (KF) ≤0.50%
Zotsalira pa Ignition ≤0.20%
Chidetso Chimodzi ≤0.30%
Zonse Zonyansa ≤0.50%
Test Standard Enterprise Standard
Kugwiritsa ntchito Pharmaceutical Intermediates;Macitentan Intermediate

Phukusi & Kusunga:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi zofunika kasitomala.

Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi.

Ubwino:

1

FAQ:

Ntchito:

5-Bromo-2-Chloropyrimidine (CAS: 32779-36-5) imagwiritsidwa ntchito ngati mankhwala apakatikati, mu kaphatikizidwe ka Active Pharmaceutical Ingredients (APIs).Amagwiritsidwanso ntchito pakuphatikizana kwa indium organometallics ndi 2,5-Dihalopyrimidines.5-Bromo-2-Chloropyrimidine ndi yapakatikati ya Macitentan (CAS: 441798-33-0).Macitentan adalandira chivomerezo cha US FDA mu Okutobala 2013 kuti azichiza matenda a pulmonary arterial hypertension (PAH) (gulu la WHO I) kuti achedwetse kukula kwa matenda.

Lembani uthenga wanu apa ndikutumiza kwa ife